Akers Biosciences Inc (AKER) - Product Pipeline Analysis, 2018 Update

Akers Biosciences Inc (AKER) - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME282PD
  • |
  • Pages: 45
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. ABI provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell separation, and synthetic macrocycle complex. The company serves medical clinicians, individuals, corporations, and law enforcement agencies, health professionals. ABI is headquartered in West Deptford, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Akers Biosciences Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Akers Biosciences Inc Company Overview 5

Akers Biosciences Inc Company Snapshot 5

Akers Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Akers Biosciences Inc - Pipeline Analysis Overview 8

Akers Biosciences Inc - Key Facts 8

Akers Biosciences Inc - Major Products and Services 9

Akers Biosciences Inc Pipeline Products by Development Stage 10

Akers Biosciences Inc Pipeline Products Overview 12

Breath PulmoHealth Check - COPD 12

Breath PulmoHealth Check - COPD Product Overview 12

Breath PulmoHealth Check - Lung Cancer 13

Breath PulmoHealth Check - Lung Cancer Product Overview 13

BreathScan Asthma 14

BreathScan Asthma Product Overview 14

BreathScan DKA 15

BreathScan DKA Product Overview 15

BreathScan THC 16

BreathScan THC Product Overview 16

Diagnostic Test - Heart Attack 17

Diagnostic Test - Heart Attack Product Overview 17

Handheld Electronic Reader 18

Handheld Electronic Reader Product Overview 18

minDNAnalyzer 19

minDNAnalyzer Product Overview 19

PIFA Chlamydia Rapid Assay 20

PIFA Chlamydia Rapid Assay Product Overview 20

PIFA Hep B / Hep C 21

PIFA Hep B / Hep C Product Overview 21

PIFA HIV 1+2 Rapid Assay 22

PIFA HIV 1+2 Rapid Assay Product Overview 22

PIFA PLUSS - Troponin I 23

PIFA PLUSS - Troponin I Product Overview 23

PIFA PLUSS Malaria Rapid Assay 24

PIFA PLUSS Malaria Rapid Assay Product Overview 24

Akers Biosciences Inc - Key Competitors 25

Akers Biosciences Inc - Key Employees 26

Akers Biosciences Inc - Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Joint Venture 27

Recent Developments 28

Akers Biosciences Inc, Recent Developments 28

Jul 18, 2018: Akers biosciences signs a further independent sales representative organization for Heparin PF4 Rapid Test covering additional 12 states 28

Jul 13, 2018: Akers Biosciences Announces Q1 2018 Earnings 28

Jul 03, 2018: Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test 35

Jun 29, 2018: Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange 35

May 29, 2018: Akers Biosciences Announces Board Change 36

May 29, 2018: Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation 36

May 25, 2018: Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq 36

Apr 26, 2018: Akers Biosciences: Directorate Change 36

Apr 12, 2018: Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test 37

Apr 03, 2018: Akers Biosciences Reports Earnings for Fiscal Year 2017 37

Appendix 42

Methodology 42

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Akers Biosciences Inc Pipeline Products by Equipment Type 6

Akers Biosciences Inc Pipeline Products by Development Stage 10

List of Tables

Akers Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Akers Biosciences Inc Pipeline Products by Equipment Type 6

Akers Biosciences Inc Pipeline Products by Indication 7

Akers Biosciences Inc, Key Facts 8

Akers Biosciences Inc, Major Products and Services 9

Akers Biosciences Inc Number of Pipeline Products by Development Stage 10

Akers Biosciences Inc Pipeline Products Summary by Development Stage 11

Breath PulmoHealth Check - COPD - Product Status 12

Breath PulmoHealth Check - COPD - Product Description 12

Breath PulmoHealth Check - Lung Cancer - Product Status 13

Breath PulmoHealth Check - Lung Cancer - Product Description 13

BreathScan Asthma - Product Status 14

BreathScan Asthma - Product Description 14

BreathScan DKA - Product Status 15

BreathScan DKA - Product Description 15

BreathScan THC - Product Status 16

BreathScan THC - Product Description 16

Diagnostic Test - Heart Attack - Product Status 17

Diagnostic Test - Heart Attack - Product Description 17

Handheld Electronic Reader - Product Status 18

Handheld Electronic Reader - Product Description 18

minDNAnalyzer - Product Status 19

minDNAnalyzer - Product Description 19

PIFA Chlamydia Rapid Assay - Product Status 20

PIFA Chlamydia Rapid Assay - Product Description 20

PIFA Hep B / Hep C - Product Status 21

PIFA Hep B / Hep C - Product Description 21

PIFA HIV 1+2 Rapid Assay - Product Status 22

PIFA HIV 1+2 Rapid Assay - Product Description 22

PIFA PLUSS - Troponin I - Product Status 23

PIFA PLUSS - Troponin I - Product Description 23

PIFA PLUSS Malaria Rapid Assay - Product Status 24

PIFA PLUSS Malaria Rapid Assay - Product Description 24

Akers Biosciences Inc, Key Employees 26

Akers Biosciences Inc, Subsidiaries 27

Akers Biosciences Inc, Joint Venture 27

Glossary 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Meridian Bioscience Inc

PositiveID Corp

Becton Dickinson and Co

Akers Biosciences Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 54128
Site License
USD 1500 INR 108255
Corporate User License
USD 2250 INR 162383

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com